Doxylin is a medicine containing the active ingredient(s) doxycycline. On this page you will find out more about Doxylin, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: doxycycline
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Doxylin 50 mg film-coated tablet, 25
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
NOTE: the 50mg tablet is not a paediatric formulation. Doxycycline is indicated in the treatment of infections caused by the following microorganisms: Mycoplasma pneumoniae: primary atypical pneumonia; Rickettsiae: Queensland tick typhus, epidemic typhus fever, Q fever, murine endemic typhus fever, Australo-Pacific endemic scrub typhus; Chlamydia psittaci: psittacosis; Calymmatobacterium (Donovania) granulomitis: granuloma inguinale; Chlamydia trachomatis: lymphogranuloma venereum, trachoma, inclusion conjunctivitis (Doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis may be treated with oral doxycycline alone, or in combination with topical agents.); Borrelliae: relapsing fever. Doxycycline is indicated in the treatment of infections caused by the following Gram-negative microorganisms: Vibrio species: cholera; Brucella species: Brucellosis (in conjunction with streptomycin); Haemophilus ducreyi: chancroid; Yersinia pestis: plague; Francisella tularensis: tularaemia; Bartonella bacilliformis: Bartonellosis; Bacteroides species. Doxycycline is active against both pre-erythrocytic and asexual bloodstages of Plasmodium falciparum. The tetracyclines are only partially active against the pre-erythrocytic stages of Plasmodium vivax, and protection depends on drug suppression of the blood stages. Doxycycline has no activity against the relapsing forms (hypnozoites) of Plasmodium vivax. Doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by Plasmodium falciparum and, in combination with other anitmalarial agents, against malaria caused by Plasmodium vivax. Doxycycline is only able to suppress malaria caused by P. vivax. As there are relatively few locations where P. vivax does not co-exist to some extent with P. falciparum, it is recommended that doxycycline should be used routinely with other agents, eg. chloroquine. When penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: Treponema pallidum: syphilis; Treponema pertenue: yaws; Neisseria gonorrhoeae: gonorrhoea. Doxycycline may be a useful adjunct to amoebicides in the treatment of acute intestinal amoebiasis. In the treatment of severe acne, doxycycline may be a useful adjunctive therapy. Doxycycline is not the drug of choice in the following: Any type of staphylococcal infection or infections caused by Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, Enterococcus faecalis, or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. Doxylin should not be used for these infections unless the organism has been shown to be sensitive. For upper respiratory infections due to group A B-haemolytic streptococci, (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice.
Table of characteristics
7mm normal convex, yellow film coated tablet, debossed DE over 50 on one side, G on the reverse.
Images are the copyright of the Pharmacy Guild of Australia
|Dosage Form||Tablet, film coated|
|Route of administration||Oral|
25 tablets: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||No information available|
|Life time||30 Months|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 March 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.